Evidence map›Paper›PMID 34337532›Full record

ArticleEuropean urology open science2021

Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank.

Richard J Fantus, Rong Na, Jun Wei, Zhuqing Shi, W Kyle Resurreccion, Joshua A Halpern, Omar Franco, Simon W Hayward, William B Isaacs, S Lilly Zheng and 2 more

Open access · goldAbstract read
In one paragraph

Article in European urology open science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic determinants of plasma testosterone in male blood donors are associated with altered red blood cell characteristics and survival in cold storage and after transfusion.Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Richard J FantusProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Rong NaProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Jun WeiProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Zhuqing ShiProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
W Kyle ResurreccionProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Joshua A HalpernFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Omar FrancoProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Simon W HaywardProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
William B IsaacsDepartment of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S Lilly ZhengProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Jianfeng XuProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
Brian T HelfandProgram for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, IL, USA.
NorthShore University HealthSystem · USNorthwestern University · USJohns Hopkins University · US

Funding

Medical Research Council MC_PC_17228Medical Research Council MC_QA137853
6 · The paper itself

Abstract

backgroundDespite strong evidence of heritability, few studies have attempted to unveil the genetic underpinnings of testosterone levels.

objectiveTo identify testosterone-associated loci in a large study and assess their biological and clinical implications. DESIGN SETTING AND

participantsThe participants were men from the UK Biobank. A two-stage genome-wide association study (GWAS) was first used to identify/validate loci for low testosterone (LowT, <8 nmol/l) in 80% of men ( OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Associations of single nucleotide polymorphisms (SNPs) with LowT were tested using an additive model. Analyses of the expression quantitative trait loci (eQTLs) were performed to assess the associations between significant SNPs and expression of nearby genes (within 1 Mbp). A genetic risk score (GRS) was used to assess the cumulative effect of multiple independent SNPs on LowT risk. RESULTS AND LIMITATIONS: The two-stage GWAS found SNPs in 141 loci of 41 cytobands that were significantly associated with LowT (

conclusionsIdentification of the genetic variants associated with LowT may improve our understanding of its etiology and identify high-risk men for LowT screening. PATIENT SUMMARY: We identified 141 new genetic loci that can be incorporated into a genetic risk score that can potentially identify men with low testosterone.

Indexed as

Expression quantitative trait locusGenetic risk scoreGenome-wide association studyTestosterone

Identifiers

PMID34337532
PMCPMC8317803
OpenAlexW3165204827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.